MTX vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

MTX

43.7
AI Score
VS
CBT Wins

CBT

63.0
AI Score

Investment Advisor Scores

MTX

44score
Recommendation
HOLD

CBT

63score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MTX CBT Winner
Revenue 2.73B 1.10B CBT
Net Income 147.00M -147.40M CBT
Gross Margin 22.1% 24.2% MTX
Net Margin 5.4% -13.5% CBT
Operating Income 356.00M -161.60M CBT
ROE 9.2% -9.5% CBT
ROA 3.7% -4.2% CBT
Total Assets 3.98B 3.50B CBT
Cash 250.00M 342.20M MTX
Debt/Equity 0.52 0.62 CBT
Current Ratio 1.47 1.43 CBT
Free Cash Flow 126.00M 44.80M CBT

Relative Price Performance (Last 90 Days)

MTX 1M: -6.4% · 3M: -10.7% CBT 1M: -5.9% · 3M: -11.0%

Current Technical Phase

MTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.6%), weak momentum, RSI 38

RSI (14): 38.5 · Price: $66.42

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $77.94

Fundamentals Snapshot

Metric MTX CBT
Market Cap — —
Forward P/E 9.3 10.9
Trailing P/E — 21.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS -2.22 3.53
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.